Hepatic hydrothorax is defined as a pleural effusion in a patient with cirr
hosis of the liver and no cardiopulmonary disease. The estimated prevalence
of this often debilitating complication in patients with liver cirrhosis i
s 4% to 10%. Its pathophysiology involves movement of ascitic fluid from th
e peritoneal cavity into the pleural space through diaphragmatic defects. A
s a result patients are at increased risk of respiratory infection. Initial
management consists of sodium restriction, diuretics, and thoracentesis. A
transjugular intrahepatic portosystemic shunt may be required. Because mos
t patients with hepatic hydrothorax have end-stage liver disease, a liver t
ransplant should be considered if these options fail. Am I Med. (C) 1999 by
Excerpta Medica, Inc.